Synbio Tech Current Assets

Synbio Tech (1295.TWO) currently reports a current assets of $910M as of June 2026. That compares with $880M in the prior-year period — up 3.5% year over year. Use the charts on this page to explore Synbio Tech's current assets history and peer comparisons.

Synbio Tech's current assets increased from $880M to $910M — a 3.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Synbio Tech reported $910M in current assets as of June 2026. That compares with $880M in the prior-year period — up 3.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $910M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Synbio Tech, and consider following 1295.TWO for alerts when major investors trade the stock.

Synbio Tech is classified in the Healthcare sector. On current assets, it currently shows $910M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 1295.TWO with unrelated industries.